Today, the International Rett derangement foot (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational inquest program to test conceivable therapeutics for Rett disease in mouse models of the disease. The funds will be awarded through the IRSF's new forward Neurotherapeutic Grant of Excellence (ANGEL) gizmo which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett disease legwork* funding, supporting nearly $21 million in anatomy programs to date. This is the first ANGEL Grant supported by IRSF in 2010.

More: - Continued here